English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Confirmation of the cholinergic specificity of the Chol-1 gangliosides in mammalian brain using affinity-purified antisera and lesions affecting the cholinergic input to the hippocampus.

MPS-Authors
/persons/resource/persons14976

Derrington,  E.A.
Abteilung Neurochemie, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15500

Masco,  D.
Abteilung Neurobiologie, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons16015

Whittaker,  V. P.
Abteilung Neurochemie, MPI for biophysical chemistry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)

2358991.pdf
(Publisher version), 881KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Derrington, E., Masco, D., & Whittaker, V. P. (1989). Confirmation of the cholinergic specificity of the Chol-1 gangliosides in mammalian brain using affinity-purified antisera and lesions affecting the cholinergic input to the hippocampus. Journal of Neurochemistry, 53(6), 1686-1692. doi:10.1111/j.1471-4159.1989.tb09231.x.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002B-B8C6-4
Abstract
An antiserum raised to Torpedo electromotor synaptosomal membranes (anti-TSM antiserum) induces a cho-linergic-specific immune lysis of mammalian brain synap-tosomes and recognizes a group of minor gangliosides in mammalian brain. These minor gangliosides appeared, therefore, to be specific to the cholinergic neuron and were designated Chol-1. To confirm the cholinergic specificity of the Chol-1 gangliosidic antigens, we have shown that not only does a mammalian ganglioside fraction that is enriched with respect to the Chol-1 gangliosides inhibit the cholinergic-specific immune lysis induced by the anti-TSM antiserum, but also it can be used to affinity-purify a subpopulation of immunoglobulins from the anti-TSM antiserum that also induce a cholinergic-specific lysis. Furthermore, we have demonstrated that fimbrial lesions, which cause a massive degeneration of cholinergic terminals in the ipsilateral hippocampus, lead to a loss of the Chol-1 gangliosides concomitant with that shown by choline acetyl transferase activity and that lesions to the entorhinal cortex, which cause a loss of mainly glutamergic synapses in the ipsilateral dentate gyrus leading to cholinergic sprouting from adjacent hippocampal areas and an increase in cholinergic markers in the dentate gyrus, produce concomitant increases in choline acetyltransferase activity and Chol-1 content. These results provide strong evidence in favour of the cholinergic specificity of the Chol-1 gangliosides